In addition, the multivariate regression analysis of GEO data also suggested that in patients with ABC-DLBCL who achieved complete remission after R-CHOP treatment, high CCND2 expression was an independent progression-free survival risk factor. This evidence concerns the gene CCND2 and diffuse large B-cell lymphoma.